Immunization and MS: A summary of published evidence and recommendations

Olivier T. Rutschmann, Douglas C. McCrory, David B. Matchar, Dennis Bourdette, Lois Copperman, Patricia Coyle, Frank DeStafano, Thomas Marrie, Deborah Miller, Cindy Phair, John Richert, Douglas S. Goodin, Carmel Armon, Elliot M. Frohman, Robert S. Goldman, David Hammond, Chung Y. Hsu, Andres M Kanner, David S. Lefkowitz, Isaac E. SilvermanMichael A. Sloan, Yuen T. So

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Objective: To review the risk of MS exacerbations after infectious episodes potentially preventable by vaccination, and the risks and benefits of immunizing patients with MS. Methods: The authors searched MEDLINE (1966 to January 2001; U.S. National Library of Medicine, Bethesda, MD), HealthSTAR, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) database (Cinahl Information Systems, Glendale, CA) for English-language articles. Each study was summarized and rated for quality of evidence. Then feasible data were pooled and analyzed in metaanalysis. Results: The risk of contracting common infectious diseases in patients with MS is not well established. There is strong evidence for an increased risk of MS exacerbations during weeks around an infectious episode. There is strong evidence against an increased risk of MS exacerbation after influenza immunization. There is no evidence that hepatitis B, varicella, tetanus, or Bacille Calmette-Guerin vaccines increase the risk of MS exacerbations. Insufficient evidence was found for other vaccines. Conclusions: Evidence supports 1) strategies to minimize the risk of acquiring infectious diseases that may trigger exacerbations of MS; and 2) the safety of using influenza, hepatitis B, varicella, tetanus, and Bacille Calmette-Guerin (BCG) vaccines in patients with MS.

Original languageEnglish (US)
Pages (from-to)1837-1843
Number of pages7
JournalNeurology
Volume59
Issue number12
StatePublished - Dec 24 2002
Externally publishedYes

Fingerprint

Immunization
BCG Vaccine
Chickenpox
Tetanus
Hepatitis B
Human Influenza
Communicable Diseases
National Library of Medicine (U.S.)
Information Systems
MEDLINE
Vaccination
Nursing
Language
Vaccines
Databases
Safety
Health

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Rutschmann, O. T., McCrory, D. C., Matchar, D. B., Bourdette, D., Copperman, L., Coyle, P., ... So, Y. T. (2002). Immunization and MS: A summary of published evidence and recommendations. Neurology, 59(12), 1837-1843.

Immunization and MS : A summary of published evidence and recommendations. / Rutschmann, Olivier T.; McCrory, Douglas C.; Matchar, David B.; Bourdette, Dennis; Copperman, Lois; Coyle, Patricia; DeStafano, Frank; Marrie, Thomas; Miller, Deborah; Phair, Cindy; Richert, John; Goodin, Douglas S.; Armon, Carmel; Frohman, Elliot M.; Goldman, Robert S.; Hammond, David; Hsu, Chung Y.; Kanner, Andres M; Lefkowitz, David S.; Silverman, Isaac E.; Sloan, Michael A.; So, Yuen T.

In: Neurology, Vol. 59, No. 12, 24.12.2002, p. 1837-1843.

Research output: Contribution to journalArticle

Rutschmann, OT, McCrory, DC, Matchar, DB, Bourdette, D, Copperman, L, Coyle, P, DeStafano, F, Marrie, T, Miller, D, Phair, C, Richert, J, Goodin, DS, Armon, C, Frohman, EM, Goldman, RS, Hammond, D, Hsu, CY, Kanner, AM, Lefkowitz, DS, Silverman, IE, Sloan, MA & So, YT 2002, 'Immunization and MS: A summary of published evidence and recommendations', Neurology, vol. 59, no. 12, pp. 1837-1843.
Rutschmann OT, McCrory DC, Matchar DB, Bourdette D, Copperman L, Coyle P et al. Immunization and MS: A summary of published evidence and recommendations. Neurology. 2002 Dec 24;59(12):1837-1843.
Rutschmann, Olivier T. ; McCrory, Douglas C. ; Matchar, David B. ; Bourdette, Dennis ; Copperman, Lois ; Coyle, Patricia ; DeStafano, Frank ; Marrie, Thomas ; Miller, Deborah ; Phair, Cindy ; Richert, John ; Goodin, Douglas S. ; Armon, Carmel ; Frohman, Elliot M. ; Goldman, Robert S. ; Hammond, David ; Hsu, Chung Y. ; Kanner, Andres M ; Lefkowitz, David S. ; Silverman, Isaac E. ; Sloan, Michael A. ; So, Yuen T. / Immunization and MS : A summary of published evidence and recommendations. In: Neurology. 2002 ; Vol. 59, No. 12. pp. 1837-1843.
@article{4845fe597b70481fbfa65926398ff7f7,
title = "Immunization and MS: A summary of published evidence and recommendations",
abstract = "Objective: To review the risk of MS exacerbations after infectious episodes potentially preventable by vaccination, and the risks and benefits of immunizing patients with MS. Methods: The authors searched MEDLINE (1966 to January 2001; U.S. National Library of Medicine, Bethesda, MD), HealthSTAR, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) database (Cinahl Information Systems, Glendale, CA) for English-language articles. Each study was summarized and rated for quality of evidence. Then feasible data were pooled and analyzed in metaanalysis. Results: The risk of contracting common infectious diseases in patients with MS is not well established. There is strong evidence for an increased risk of MS exacerbations during weeks around an infectious episode. There is strong evidence against an increased risk of MS exacerbation after influenza immunization. There is no evidence that hepatitis B, varicella, tetanus, or Bacille Calmette-Guerin vaccines increase the risk of MS exacerbations. Insufficient evidence was found for other vaccines. Conclusions: Evidence supports 1) strategies to minimize the risk of acquiring infectious diseases that may trigger exacerbations of MS; and 2) the safety of using influenza, hepatitis B, varicella, tetanus, and Bacille Calmette-Guerin (BCG) vaccines in patients with MS.",
author = "Rutschmann, {Olivier T.} and McCrory, {Douglas C.} and Matchar, {David B.} and Dennis Bourdette and Lois Copperman and Patricia Coyle and Frank DeStafano and Thomas Marrie and Deborah Miller and Cindy Phair and John Richert and Goodin, {Douglas S.} and Carmel Armon and Frohman, {Elliot M.} and Goldman, {Robert S.} and David Hammond and Hsu, {Chung Y.} and Kanner, {Andres M} and Lefkowitz, {David S.} and Silverman, {Isaac E.} and Sloan, {Michael A.} and So, {Yuen T.}",
year = "2002",
month = "12",
day = "24",
language = "English (US)",
volume = "59",
pages = "1837--1843",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Immunization and MS

T2 - A summary of published evidence and recommendations

AU - Rutschmann, Olivier T.

AU - McCrory, Douglas C.

AU - Matchar, David B.

AU - Bourdette, Dennis

AU - Copperman, Lois

AU - Coyle, Patricia

AU - DeStafano, Frank

AU - Marrie, Thomas

AU - Miller, Deborah

AU - Phair, Cindy

AU - Richert, John

AU - Goodin, Douglas S.

AU - Armon, Carmel

AU - Frohman, Elliot M.

AU - Goldman, Robert S.

AU - Hammond, David

AU - Hsu, Chung Y.

AU - Kanner, Andres M

AU - Lefkowitz, David S.

AU - Silverman, Isaac E.

AU - Sloan, Michael A.

AU - So, Yuen T.

PY - 2002/12/24

Y1 - 2002/12/24

N2 - Objective: To review the risk of MS exacerbations after infectious episodes potentially preventable by vaccination, and the risks and benefits of immunizing patients with MS. Methods: The authors searched MEDLINE (1966 to January 2001; U.S. National Library of Medicine, Bethesda, MD), HealthSTAR, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) database (Cinahl Information Systems, Glendale, CA) for English-language articles. Each study was summarized and rated for quality of evidence. Then feasible data were pooled and analyzed in metaanalysis. Results: The risk of contracting common infectious diseases in patients with MS is not well established. There is strong evidence for an increased risk of MS exacerbations during weeks around an infectious episode. There is strong evidence against an increased risk of MS exacerbation after influenza immunization. There is no evidence that hepatitis B, varicella, tetanus, or Bacille Calmette-Guerin vaccines increase the risk of MS exacerbations. Insufficient evidence was found for other vaccines. Conclusions: Evidence supports 1) strategies to minimize the risk of acquiring infectious diseases that may trigger exacerbations of MS; and 2) the safety of using influenza, hepatitis B, varicella, tetanus, and Bacille Calmette-Guerin (BCG) vaccines in patients with MS.

AB - Objective: To review the risk of MS exacerbations after infectious episodes potentially preventable by vaccination, and the risks and benefits of immunizing patients with MS. Methods: The authors searched MEDLINE (1966 to January 2001; U.S. National Library of Medicine, Bethesda, MD), HealthSTAR, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) database (Cinahl Information Systems, Glendale, CA) for English-language articles. Each study was summarized and rated for quality of evidence. Then feasible data were pooled and analyzed in metaanalysis. Results: The risk of contracting common infectious diseases in patients with MS is not well established. There is strong evidence for an increased risk of MS exacerbations during weeks around an infectious episode. There is strong evidence against an increased risk of MS exacerbation after influenza immunization. There is no evidence that hepatitis B, varicella, tetanus, or Bacille Calmette-Guerin vaccines increase the risk of MS exacerbations. Insufficient evidence was found for other vaccines. Conclusions: Evidence supports 1) strategies to minimize the risk of acquiring infectious diseases that may trigger exacerbations of MS; and 2) the safety of using influenza, hepatitis B, varicella, tetanus, and Bacille Calmette-Guerin (BCG) vaccines in patients with MS.

UR - http://www.scopus.com/inward/record.url?scp=0037168795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037168795&partnerID=8YFLogxK

M3 - Article

C2 - 12499473

AN - SCOPUS:0037168795

VL - 59

SP - 1837

EP - 1843

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 12

ER -